131 related articles for article (PubMed ID: 29545453)
41. [A case of MPO-ANCA positive vasculitis associated with multiple pulmonary nodules following propylthiouracil treatment].
Shimizudani N; Senba S; Odaka T; Utsumi K; Nemoto K; Hatao H; Ito M; Adachi H; Kishi K; Oh-ishi S; Nakamura H; Matsuoka T
Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):98-103. PubMed ID: 19260531
[TBL] [Abstract][Full Text] [Related]
42. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
43. Myeloperoxidase antineutrophil cytoplasmic antibody positive vasculitis during propylthiouracil treatment: successful management with oral corticosteroids.
Matsubara K; Nigami H; Harigaya H; Osaki M; Baba K
Pediatr Int; 2000 Apr; 42(2):170-3. PubMed ID: 10804735
[No Abstract] [Full Text] [Related]
44. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.
Kudoh Y; Kuroda S; Shimamoto K; Iimura O
Clin Nephrol; 1997 Jul; 48(1):41-3. PubMed ID: 9247777
[TBL] [Abstract][Full Text] [Related]
45. [A woman in her forties with influenza symptoms and swollen arm].
Lillejordet E; Rashid HU; Evang JA; Taraldsrud E; Gunnarsson R
Tidsskr Nor Laegeforen; 2019 Jan; 139(1):. PubMed ID: 30644687
[No Abstract] [Full Text] [Related]
46. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.
Choi HK; Merkel PA; Walker AM; Niles JL
Arthritis Rheum; 2000 Feb; 43(2):405-13. PubMed ID: 10693882
[TBL] [Abstract][Full Text] [Related]
47. VISUAL VIGNETTE.
Sandhu SS; Dhindsa SS; Kuhadiya ND; Dandona P
Endocr Pract; 2018 Nov; 24(11):1019. PubMed ID: 30106633
[No Abstract] [Full Text] [Related]
48. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
[TBL] [Abstract][Full Text] [Related]
49. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy.
Erten Y; Bodur H; Sahiner S; Tolunay O; Akkaya V; Canbakan B; Bali M
Clin Endocrinol (Oxf); 2002 Nov; 57(5):699-700. PubMed ID: 12390348
[No Abstract] [Full Text] [Related]
50. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
[TBL] [Abstract][Full Text] [Related]
51. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
52. [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].
Boulenger-Vazel A; Kupfer-Bessaguet I; Gouedard C; Leberre R; Leroy JP; Sonnet E; Desvignes O; Misery L; Sassolas B
Ann Dermatol Venereol; 2005 Jan; 132(1):27-31. PubMed ID: 15746603
[TBL] [Abstract][Full Text] [Related]
53. Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies (ANCA) skin vasculitis: the first case reported in Croatia.
Anić B; Baresić M; Cerovec M; Mayer M; Bosnić D; Sentić M; Cikes N
Acta Dermatovenerol Croat; 2010; 18(2):104-6. PubMed ID: 20624360
[TBL] [Abstract][Full Text] [Related]
54. Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed after 17 years of propylthiouracil therapy.
Taguchi T; Nakayama S; Fujimoto S; Terada Y
Endocrine; 2014 Jun; 46(2):357-9. PubMed ID: 24272591
[No Abstract] [Full Text] [Related]
55. Crescentic glomerulonephritis due to IgA nephropathy or propylthiouracil-induced Mpo-Anca positive vasculitis?
Ozkok A; Makbule Sirin B; Celal Elcioglu O; Bakan A; Riza Odabas A
Ren Fail; 2013 Jul; 35(6):930. PubMed ID: 23682719
[No Abstract] [Full Text] [Related]
56. [Myeloperoxidase-antineutrophil cytoplasmic antibody positive alveolar hemorrhage during propylthiouracil therapy for hyperthyroidism].
Makiyama Y; Ito M; Akiyama F; Sega H; Togashi K; Hasegawa T; Suzuki E; Arakawa M; Gejyo F
Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):201-5. PubMed ID: 10846402
[TBL] [Abstract][Full Text] [Related]
57. [Anti neutrophil cytoplasmatic antibodies-positive vasculitis as a complication of hyperthyreosis treatment with propylthiouracil].
Wiśniewski P; Lewczuk A; Czaplińska-Kałas H; Porzezińska M; Sworczak K
Pol Merkur Lekarski; 2005 Nov; 19(113):674-7. PubMed ID: 16498810
[TBL] [Abstract][Full Text] [Related]
58. [Propylthiouracil-induced multispecific antineutrophil cytoplasmic antibodies].
Servonnet A; Garcia-Hejl C; Banal F; Ramirez J; Fontan E
Rev Med Interne; 2010 Oct; 31(10):e9-e10. PubMed ID: 20605662
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
